ADT 2001 Annual Report Download - page 82

Download and view the complete annual report

Please find page 82 of the 2001 ADT annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 94

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94

80
Summarized quarterly financial data for Fiscal 2000 are presented below.
FOR THE YEAR ENDED SEPTEMBER 30, 2000
($ IN MILLIONS, EXCEPT PER SHARE DATA) 1ST QTR.(1) 2ND QTR.(2) 3RD QTR.(3) 4TH QTR.(4)
Total revenues $6,638.8 $7,070.0 $7,417.8 $9,565.3
Income before extraordinary items 757.2 855.5 997.3 1,910.1
Net income(5) 757.0 855.5 997.3 1,910.1
BASIC INCOME PER COMMON SHARE:
Income before extraordinary items $ 0.45 $ 0.51 $ 0.59 $ 1.13
Net income per common share 0.45 0.51 0.59 1.13
DILUTED INCOME PER COMMON SHARE:
Income before extraordinary items $ 0.44 $ 0.50 $ 0.58 $ 1.12
Net income per common share 0.44 0.50 0.58 1.12
(1) Includes charges for the impairment of long-lived assets of $99.0 million and restructuring and other non-recurring charges of $7.9 million, of which charges of $6.4 million are included
in cost of revenue, related to exiting U.S. Surgical’s interventional cardiology business; restructuring and other non-recurring charges of $7.7 million related to U.S. Surgical’s suture busi-
ness; and restructuring charges of $6.5 million related to AMP’s Brazilian operations. Also includes a credit of $94.7 million representing a revision in estimates of merger, restructuring
and other non-recurring accruals, consisting of $57.8 million related to the merger with AMP and AMP’s profit improvement plan, $15.5 million related primarily to the merger with U.S.
Surgical and $21.4 million related to the Company’s 1997 restructuring accruals.
(2) Includes merger, restructuring and other non-recurring charges of $10.4 million, of which charges of $0.9 million are included in cost of revenue, primarily related to activities in AMP’s
wireless communications business and restructuring and other non-recurring charges of $0.5 million related to U.S. Surgical’s suture business. Also includes a credit of $12.7 million, of
which a credit of $6.3 million is included in cost of revenue, primarily representing a revision of estimates of merger, restructuring and other non-recurring accruals related to the merger
with AMP and AMP’s profit improvement plan.
(3) Includes restructuring and other non-recurring charges of $2.9 million related to U.S. Surgical’s suture business. Also includes a merger, restructuring and other non-recurring credit
of $9.8 million representing a revision of estimates of merger, restructuring and other non-recurring accruals related to the merger with AMP and AMP’s profit improvement plan.
(4) Includes a non-recurring gain on issuance of common shares by subsidiary of $1,760.0 million. Also includes charges of $275.0 million as a reserve for certain claims relating to a
merged company in the Healthcare business, a non-recurring charge of $13.1 million incurred in connection with the TyCom IPO and other non-recurring charges of $1.2 million. Also
includes credits of $27.5 million and $4.2 million representing a revision of estimates of merger, restructuring and other non-recurring accruals related to the merger with AMP and AMP’s
profit improvement plan and the merger with U.S. Surgical, respectively.
(5) Extraordinary items relate principally to the early extinguishment of debt.